Jan 04, 2024 / 06:30PM GMT
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Given we're running a few minutes late, let's get started. Thanks for joining us for our next session with IDEXX Labs. They're a leading provider of diagnostic solutions for the animal health industry. Very pleased to have Jay Mazelsky, President and CEO, with us today, and John Ravis from IR in the audience. My name is Nathan Rich, and I cover the animal health space here at Goldman Sachs.
Questions and Answers:
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research AnalystMaybe to start, Jay, just keeping it high level, could you frame the company's performance in 2023 and then looking forward, kind of what do you see as the state of the industry and kind of strategic priorities for the business in 2024?
Jonathan J. Mazelsky - IDEXX Laboratories, Inc. - President, CEO & Director
Sure. Glad too, Nathan. Thanks for having us. I appreciate it. Yes, I always like -- let me just first start off